TNF and neurosarcoidosis: Corticosteroids are well stablished as the first line therapy of neurosarcoidosis, and were administered in 83% of cases included in the systematic review by Fritz et al.31, followed by oral immunosuppressive agents as second line therapies in 27% and TNF-alpha antagonists in 4%.